NYSE:MET

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses worldwide. More Details


Snowflake Analysis

Undervalued established dividend payer.


Similar Companies

Share Price & News

How has MetLife's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MET is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: MET's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

-6.3%

MET

-5.6%

US Insurance

-2.7%

US Market


1 Year Return

-4.1%

MET

-8.1%

US Insurance

21.2%

US Market

Return vs Industry: MET exceeded the US Insurance industry which returned -5.2% over the past year.

Return vs Market: MET underperformed the US Market which returned 24.3% over the past year.


Shareholder returns

METIndustryMarket
7 Day-6.3%-5.6%-2.7%
30 Day4.7%-1.9%1.8%
90 Day29.8%14.2%16.4%
1 Year0.5%-4.1%-5.4%-8.1%23.9%21.2%
3 Year13.7%0.7%7.5%-0.6%43.7%34.2%
5 Year54.1%15.4%66.0%45.1%124.3%99.2%

Long-Term Price Volatility Vs. Market

How volatile is MetLife's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is MetLife undervalued compared to its fair value and its price relative to the market?

27.1%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: MET ($48.41) is trading below our estimate of fair value ($66.45)

Significantly Below Fair Value: MET is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: MET is good value based on its PE Ratio (7.9x) compared to the US Insurance industry average (14.4x).

PE vs Market: MET is good value based on its PE Ratio (7.9x) compared to the US market (21.2x).


Price to Earnings Growth Ratio

PEG Ratio: MET's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: MET is good value based on its PB Ratio (0.6x) compared to the US Insurance industry average (1x).


Next Steps

Future Growth

How is MetLife forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

-7.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MET's earnings are forecast to decline over the next 3 years (-7.1% per year).

Earnings vs Market: MET's earnings are forecast to decline over the next 3 years (-7.1% per year).

High Growth Earnings: MET's earnings are forecast to decline over the next 3 years.

Revenue vs Market: MET's revenue (3.5% per year) is forecast to grow slower than the US market (10.6% per year).

High Growth Revenue: MET's revenue (3.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MET's Return on Equity is forecast to be low in 3 years time (9.7%).


Next Steps

Past Performance

How has MetLife performed over the past 5 years?

11.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MET has high quality earnings.

Growing Profit Margin: MET's current net profit margins (8.5%) are lower than last year (10.5%).


Past Earnings Growth Analysis

Earnings Trend: MET's earnings have grown by 11.5% per year over the past 5 years.

Accelerating Growth: MET's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: MET had negative earnings growth (-22%) over the past year, making it difficult to compare to the Insurance industry average (5.9%).


Return on Equity

High ROE: MET's Return on Equity (7.9%) is considered low.


Next Steps

Financial Health

How is MetLife's financial position?


Financial Position Analysis

Short Term Liabilities: MET's short term assets ($68.7B) exceed its short term liabilities ($67.6B).

Long Term Liabilities: MET's short term assets ($68.7B) do not cover its long term liabilities ($639.3B).


Debt to Equity History and Analysis

Debt Level: MET's debt to equity ratio (150.2%) is considered high.

Reducing Debt: MET's debt to equity ratio has increased from 92.8% to 150.2% over the past 5 years.

Debt Coverage: MET's debt is not well covered by operating cash flow (10.6%).

Interest Coverage: MET's interest payments on its debt are well covered by EBIT (8.5x coverage).


Balance Sheet


Next Steps

Dividend

What is MetLife current dividend yield, its reliability and sustainability?

3.80%

Current Dividend Yield


Upcoming Dividend Payment


Dividend Yield vs Market

Notable Dividend: MET's dividend (3.8%) is higher than the bottom 25% of dividend payers in the US market (1.39%).

High Dividend: MET's dividend (3.8%) is low compared to the top 25% of dividend payers in the US market (3.87%).


Stability and Growth of Payments

Stable Dividend: MET's dividends per share have been stable in the past 10 years.

Growing Dividend: MET's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (29.3%), MET's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: MET's dividends in 3 years are forecast to be well covered by earnings (37.2% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.8yrs

Average management tenure


CEO

Michel Khalaf (56 yo)

1.67yrs

Tenure

US$14,570,581

Compensation

Mr. Michel A. Khalaf is a Director at The Geneva Association since June 10, 2020. He has been the President, Chief Executive Officer and Director of MetLife, Inc. since May 1, 2019. Mr. Khalaf served as Pr...


CEO Compensation Analysis

Compensation vs Market: Michel's total compensation ($USD14.57M) is above average for companies of similar size in the US market ($USD10.56M).

Compensation vs Earnings: Michel's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Michel Khalaf
CEO, President & Director1.67yrsUS$14.57m0.0035%
$ 1.6m
John McCallion
Executive VP & CFO2.67yrsUS$6.32m0.0034%
$ 1.5m
Bill Pappas
Executive VP and Head of Global Technology & Operations1.17yrsUS$4.69m0.0010%
$ 469.0k
Steven Goulart
Executive VP & Chief Investment Officer9.67yrsUS$7.09m0.015%
$ 6.7m
Ramy Tadros
Executive VP & President of U.S. Business3.33yrsUS$4.51m0.0020%
$ 915.5k
Tamara Schock
Executive VP & Chief Accounting Officer1.83yrsno datano data
Pawan Verma
Executive VP & Chief Information Officer0.17yrno datano data
John Hall
Senior VP & Head of Investor Relationsno datano datano data
Stephen Gauster
Executive VP & General Counsel3.5yrsno data0.00078%
$ 351.8k
Randolph Clerihue
Chief Communications Officer2.75yrsno datano data
Esther Lee
Executive VP & Global Chief Marketing Officer6yrsno data0.0048%
$ 2.2m
Susan Podlogar
Executive VP & Chief HR Officer3.5yrsno data0.0019%
$ 843.3k

2.8yrs

Average Tenure

50yo

Average Age

Experienced Management: MET's management team is considered experienced (2.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Michel Khalaf
CEO, President & Director1.67yrsUS$14.57m0.0035%
$ 1.6m
Dirk Ostijn
Executive VPno datano datano data
William Kennard
Independent Director7.33yrsUS$326.75k0%
$ 0
David Herzog
Independent Director4.25yrsUS$341.75k0.0017%
$ 771.1k
Gerald Hassell
Independent Director2.92yrsUS$301.75k0.0013%
$ 572.7k
Carlos Gutierrez
Independent Director7.83yrsUS$301.75k0.0035%
$ 1.6m
Edward Kelly
Independent Director5.92yrsUS$336.75k0.0025%
$ 1.1m
Catherine Kinney
Independent Director11.75yrsUS$306.75k0.0055%
$ 2.5m
Denise Morrison
Independent Director6.92yrsUS$302.23k0.0024%
$ 1.1m
Robert Hubbard
Independent Chairman1.67yrsUS$520.24k0.00086%
$ 387.8k
Diana McKenzie
Independent Director2.17yrsUS$301.75k0.0010%
$ 451.0k
Cheryl Grise
Independent Director16.92yrsUS$326.85k0.00052%
$ 234.5k

5.9yrs

Average Tenure

66yo

Average Age

Experienced Board: MET's board of directors are considered experienced (5.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

MetLife, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MetLife, Inc.
  • Ticker: MET
  • Exchange: NYSE
  • Founded: 1863
  • Industry: Life and Health Insurance
  • Sector: Insurance
  • Market Cap: US$45.096b
  • Shares outstanding: 899.95m
  • Website: https://www.metlife.com

Number of Employees


Location

  • MetLife, Inc.
  • 200 Park Avenue
  • New York
  • New York
  • 10166-0188
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
METNYSE (New York Stock Exchange)YesCommon StockUSUSDApr 2000
MWZDB (Deutsche Boerse AG)YesCommon StockDEEURApr 2000
MWZXTRA (XETRA Trading Platform)YesCommon StockDEEURApr 2000
MET *BMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNApr 2000
0K0XLSE (London Stock Exchange)YesCommon StockGBUSDApr 2000
METLWBAG (Wiener Boerse AG)YesCommon StockATEURApr 2000
MET.PRANYSE (New York Stock Exchange)PFD A FLT RATEUSUSDJun 2005
METB34BOVESPA (Bolsa de Valores de Sao Paulo)EACH BDR REPR 1 COM STK USD0.01BRBRLAug 2015
A19YH3DB (Deutsche Boerse AG)PERP JR SB GLBLDEUSDMar 2018
MET.PRENYSE (New York Stock Exchange)5.625 NCUM PFD EUSUSDMay 2018
MET.PRFNYSE (New York Stock Exchange)4.75% DP PFD FUSUSDJan 2020

Biography

MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Af...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/27 23:31
End of Day Share Price2021/01/27 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.